类风湿关节炎患者骨密度变化研究

段京明; 王瑞明; 卓勤俭; 孟彩云; 朱明贞; 余海林; 段京明; 王瑞明; 卓勤俭; 孟彩云; 朱明贞; 余海林

[2] 周惠琼，姚如愚，Wil RK，等.类风湿关节炎患者骨密度与疾病活动相关性的临床观察[J].中国骨质疏松杂志，2007,13 (6)419-423.

[2]

陆竞秋，张林杰，徐胜前，等.类风湿关节炎患者的骨质疏松及其相关影响因素[J].临床军医杂志，2008,36 (4):499 -501.

[3] 魏天佑.骨质疏松与类风湿关节炎[J].中国骨质疏松杂志，2007,13 (8): 592-595.

[4] 王彦焱，赵春梅，魏丽，等.药物对类风湿关节炎患者骨密度的影响[J].新疆医科大学报，2010,33 (2):172-175.

[5] 黄晓莲，刘军，王琼康，等.类风湿关节炎患者继发骨质疏松症的临床研究[J].宁夏医学杂志，2009,31(12):11581159.

[6] Solomon DH Finkelstein JS, Shadick N, et al.The RelationshipBetween focal L,rosions and Generalized Osteoporosis inPostmenopausal Women with Rheumatoid Arthritis: TheOsteoporosis in Rheumatoid Arthritis (OPiRA) Cohort Study[J].Arthritis Rheum,2009,60 (6):16241631.

[7] Hoff M, Kvien TK, Kalvesten,J, et al. Adalimumab therapy reduceshand bone loss in early rheumatoid arthritis: explorative analysesfrom the PREMIER study[J].Ann Rheum Dis, 2009, 68 (7):11711176.

[8] Brand C, Lowe A, Hall S. The utility of clinical decision tools fordiagnosing osteoporosis in postmenopausal women with rheumatoidarthritis[J].BMC Musculoskeletal Disorders 2008,9:13.

[9] Cui J,Taylor KE DeStefano AL, et al. Genome-Wide AssociationStudy of Determinants of Anti-Cyclic Citrullinated PeptideAntibody 'liter in Adults with Rheumatoid Arthritis[J].Mol Med,2009,15(5/6):136143.